#088: Immune Tolerance and MS. How the RED4MS study could change MS treatment with Dr. Andreas Lutterotti

Andreas Lutterotti explains the mode of action, the concept of the early clinical trial Red4MS, and what a success could mean for patients.

Andreas Lutterotti explains the mode of action, the concept of the early clinical trial Red4MS, and what a success could mean for patients.
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information